Concepedia

Author

Wilmin Bartolini

Ironwood Pharmaceuticals (United States)ORCID

Also Known As

W Bartolini, Wilmin Bartolini, Wilmin P. Bartolini

31

Publications

849

Citations

10

H-Index

39

Concepts

All Affiliations

Ironwood Pharmaceuticals (United States)AbbVie (United States)Jacksonville CollegeCyclerion (United States)Mayo Clinic in Florida
WB

About

Wilmin Bartolini is an author at Ironwood Pharmaceuticals (United States) specializing in medicine, biochemistry, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

572

2

Biochemistry

4

4

489

3

Natural Sciences

3

3

268

4

Health Sciences

1

1

66

5

Cell Biology

1

1

17

Wilmin Bartolini

×

11

Publications

827

Citations

10

H-Index

YearCitations

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

Robert Busby, Alexander P. Bryant, Wilmin Bartolini,

European Journal of Pharmacology

2010

245

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

Alexander P. Bryant, Robert Busby, Wilmin Bartolini,

Life Sciences

2010

221

Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Robert Busby, Marco M. Kessler, Wilmin Bartolini,

Journal of Pharmacology and Experimental Therapeutics

2012

132

Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System

Lin Chang, Brian E. Lacy, Baha Moshiree,

The American Journal of Gastroenterology

2021

66

Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation

William D. Chey, Gregory S. Sayuk, Wilmin Bartolini,

The American Journal of Gastroenterology

2020

53

Fatty Acid Amide Hydrolase (FAAH) Inhibition Reduces l-3,4-Dihydroxyphenylalanine-Induced Hyperactivity in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Lesioned Non-Human Primate Model of Parkinson’s Disease

Tom H. Johnston, Philippe Huot, Susan H. Fox,

Journal of Pharmacology and Experimental Therapeutics

2010

38

RNA Structure Inhibits the TRAP ( rp RNA-binding AttenuationProtein)-RNA Interaction

Sandhya Xirasagar, Matthew B. Elliott, Wilmin Bartolini,

Journal of Biological Chemistry

1998

21

Abstract 2156: IK-930 is a novel TEAD inhibitor for the treatment of cancers harboring mutations in the Hippo signal transduction pathway

Benjamin Amidon, Marta Sánchez-Martín, Wilmin Bartolini,

Cancer Research

2022

17

Characterizing DNA photo-oxidation reactions by high-resolution mass measurements with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Wilmin Bartolini, Murray V. Johnston

Journal of Mass Spectrometry

2000

13

Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials

Darren M. Brenner, Brian E. Lacy, Alexander C. Ford,

The American Journal of Gastroenterology

2022

11

Page 1